Explain about pharmacology graphs

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Loading Image

Those URLs were truncated. I have enough content and three high-quality images to write a thorough answer now.

Pharmacology Graphs - A Complete Guide

Pharmacology uses several types of graphs to describe how drugs behave in the body and at receptors. The major categories are: dose-response graphs, receptor binding graphs, agonist/antagonist graphs, and quantal dose-response / therapeutic index graphs.

1. Graded Dose-Response Curve

This is the most fundamental pharmacology graph. It plots the magnitude of a drug's effect (y-axis) against increasing drug concentration or dose (x-axis).

Graded Dose-Response Curve - Linear (A) and Semilogarithmic (B) plots showing EC50 for Drug A and Drug B

Figure: Panel A = linear plot; Panel B = semilogarithmic (sigmoidal) plot. The EC50 marks 50% of maximal effect.

Key features read from this graph:

Parameter	Definition	What the graph shows
EC50	Concentration producing 50% of maximal effect	Point on x-axis at 50% response - lower EC50 = more potent
Emax	Maximum effect a drug can produce	The plateau of the curve - indicates efficacy
Potency	Amount needed to produce an effect	Drug A (red) is more potent than Drug B because its EC50 is smaller
Efficacy	Magnitude of maximal response	Both drugs reach the same Emax here, so they have equal efficacy

Why semilogarithmic (log scale)? Because the range of doses spans several orders of magnitude, plotting log dose converts the hyperbolic curve into a convenient S-shaped (sigmoidal) curve, making EC50 easy to read off the graph. - Lippincott Illustrated Reviews: Pharmacology, p. 95-96

Clinical example: Candesartan (dose range 4-32 mg) vs. irbesartan (75-300 mg) are both angiotensin receptor blockers - candesartan is more potent because it requires a lower dose to achieve the same effect, but both have equal efficacy for treating hypertension.

2. Potency vs. Efficacy Graph

Dose-response curves showing differences in potency and efficacy among multiple drugs

This graph compares drugs with different potency AND efficacy simultaneously:

A drug can be more potent but less efficacious (curve shifted left but lower plateau)
A drug can be less potent but more efficacious (curve shifted right but higher plateau)
Efficacy is clinically more important - morphine's greater efficacy makes it useful for severe cancer pain, where naproxen's identical efficacy to ibuprofen (just different potency) makes them therapeutically equivalent for headache.

3. Agonist Types on Dose-Response Curves

Receptor activity vs. log drug concentration curves for full agonist, partial agonist, and inverse agonist

This graph shows three types of agonist behavior: - Lippincott Illustrated Reviews: Pharmacology, p. 101-103

Drug Type	Curve Shape	Emax	Intrinsic Activity
Full agonist	Rises to 100%	Same as endogenous ligand	= 1
Partial agonist	Rises but plateaus below full agonist	Less than full agonist, even at 100% receptor occupancy	0 to 1
Inverse agonist	Curve goes downward	Falls below baseline	< 0 (negative)
Competitive antagonist	Shifts full agonist curve to the right (same Emax)	Unchanged	= 0
Non-competitive antagonist	Lowers the Emax plateau without shifting EC50	Decreased	= 0

Partial agonist as a dual agent: A partial agonist can act as both agonist (when no full agonist is present) AND antagonist (competing with a full agonist, reducing its Emax to the partial agonist's ceiling). Aripiprazole exploits this in schizophrenia - it inhibits overactive dopamine pathways while stimulating underactive ones.

4. Effect of Antagonists - Rightward Shift

A very important graph pattern to recognize:

Competitive (reversible) antagonist - dose-response curve shifts right in parallel (same shape, same Emax, higher EC50). The effect can be overcome by increasing the agonist dose.
Non-competitive (irreversible) antagonist - curve is compressed downward (Emax falls, EC50 unchanged or altered). Cannot be reversed by adding more agonist.

5. Quantal Dose-Response Curve and Therapeutic Index

Unlike graded curves (individual responses), quantal curves show what fraction of a population responds to a given dose.

Quantal dose-response curves for warfarin (small TI) and penicillin (large TI) showing therapeutic window

Figure: Green curve = desired therapeutic response; Red curve = toxic/adverse response. Yellow zone = therapeutic window.

Key parameters:

Parameter	Definition
ED50	Dose effective in 50% of the population
TD50	Dose causing toxicity in 50% of the population
LD50	Lethal dose in 50% of the population (used in animal studies)
Therapeutic Index (TI)	TI = TD50 / ED50 - larger value = safer drug

Reading the graph:

Warfarin (Panel A): The therapeutic (green) and toxic (red) curves are close together, meaning the therapeutic window is narrow. A small dose increase above the effective range causes bleeding. This demands careful monitoring.
Penicillin (Panel B): The toxic curve is far to the right of the therapeutic curve - a very wide therapeutic window. You can give high doses without reaching toxic levels in most patients.

Drugs with low TI (digoxin, warfarin, lithium, aminoglycosides, theophylline) require therapeutic drug monitoring. - Lippincott Illustrated Reviews: Pharmacology, p. 108-110

6. Drug Concentration-Time Graph (Pharmacokinetics)

This graph plots plasma drug concentration (y-axis) vs. time after administration (x-axis):

Plasma           Peak (Cmax)
Concentration  ___
    |         /   \
    |        /     \___
    |       /           \___
    |______/                 \___
    |__________________________|___ Time
          Tmax         Half-life decay

Key features:

Cmax - peak plasma concentration
Tmax - time to peak concentration
Half-life (t½) - time for plasma concentration to fall by 50%
Area Under the Curve (AUC) - total drug exposure over time; used to calculate bioavailability
On a log scale, first-order elimination appears as a straight line (exponential decay becomes linear)
On a linear scale, elimination appears as a curve

Repeated dosing graph shows drug accumulating toward a steady state (typically reached after 4-5 half-lives) and then oscillating between a peak and trough concentration.

Summary Table of Graph Types

Graph	X-axis	Y-axis	What it tells you
Graded dose-response (linear)	Drug concentration	% maximal effect	Potency (EC50), Efficacy (Emax)
Graded dose-response (log)	Log drug concentration	% maximal effect	Sigmoidal shape; easy comparison
Receptor binding	Drug concentration	Fraction receptors bound	Affinity (Kd)
Agonist comparison	Log concentration	Receptor activity	Full vs partial vs inverse agonist
Quantal	Log dose	% population responding	ED50, TD50, Therapeutic Index
Plasma concentration-time	Time	Drug concentration	t½, Cmax, AUC, bioavailability

Source: Lippincott Illustrated Reviews: Pharmacology, 8th ed., Chapter 2 (Pharmacodynamics), pp. 95-110; Goodman & Gilman's The Pharmacological Basis of Therapeutics, Chapter 3 (Dose-Response)

This is a shared conversation. Sign in to Orris to start your own chat.